Cadila Pharmaceuticals has introduced a solution for Iron Deficiency anaemia with the unveiling of Redshot FCM, a revolutionary iron injection fortified with the advanced Ferric Carboxymallose formulation. The product, catering to both adult and paediatric patients over the age of one, particularly those with oral iron intolerance, promises to transform the landscape of anaemia treatment.
Designed to address the critical need for effective and safe anaemia management, Redshot Injection offers a superior safety profile coupled with enhanced tolerability. With minimal risk of anaphylaxis, this intravenous iron preparation accelerates the improvement of haemoglobin levels and efficiently replenishes depleted iron stores. Moreover, its intravenous delivery system facilitates the utilisation of high doses in a single administration, ensuring swift and effective treatment.